Fluorometholone modulates gene expression of ocular surface mucins.
corticosteroids
dry eye
fluorometholone
glucocorticoids
ocular mucins
ocular surface
Journal
Acta ophthalmologica
ISSN: 1755-3768
Titre abrégé: Acta Ophthalmol
Pays: England
ID NLM: 101468102
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
24
04
2018
accepted:
19
03
2019
pubmed:
10
4
2019
medline:
17
3
2020
entrez:
10
4
2019
Statut:
ppublish
Résumé
Mucins are vital to keep the ocular surface hydrated. Genes encoding for mucins contain a glucocorticoid response element. The purpose of this study was to evaluate the effect of fluorometholone, a glucocorticoid receptor agonist used in the management of dry eye, on the gene expression of conjunctival and corneal epithelial cell mucins. Stratified cultures of human conjunctival and corneal epithelial cells were exposed to 25, 50 and 100 nM of fluorometholone alone or in presence of mifepristone, a glucocorticoid receptor antagonist. The mRNA was isolated from the cells and reverse transcribed to cDNA. The cDNA was used for quantification of gene expression of mucin (MUC) 1, 4, 16 and 19 using real-time PCR. Fluorometholone caused a dose- and time-dependent increase in the gene expression of MUC1, MUC4, MUC16 and MUC19 in the conjunctival as well as corneal epithelial cells. Mifepristone, a glucocorticoid receptor antagonist, inhibited fluorometholone-mediated increase in the gene expression of conjunctival and corneal mucins. At the tested concentration, neither fluorometholone nor mifepristone caused any notable changes in the cellular phenotype or viability of conjunctival and corneal epithelial cells. Fluorometholone increases the gene expression of MUC1, MUC4, MUC16 and MUC19 in the conjunctival and corneal epithelial cells through activation of glucocorticoid receptors. The increased expression of mucins can be an additional possible mechanism contributing to the beneficial effects of fluorometholone in dry eye in addition to its well-known anti-inflammatory effects.
Substances chimiques
Glucocorticoids
0
Mucins
0
RNA, Messenger
0
Fluorometholone
SV0CSG527L
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1082-e1088Informations de copyright
© 2019 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.
Références
Ablamowicz AF & Nichols JJ (2016): Ocular surface membrane-associated mucins. Ocul Surf 14: 331-341.
Argüeso P, Balaram M, Spurr-Michaud S, Keutmann HT, Dana MR & Gipson IK (2002): Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren syndrome. Invest Ophthalmol Vis Sci 43: 1004-1011.
Avunduk AM, Avunduk MC, Varnell ED & Kaufman HE (2003): The comparison of efficacies of topical corticosteroids and non-steroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol 136: 593-602.
Bai CH, Song SY & Kim YD (2007): Effect of glucocorticoid on the MUC4 gene in nasal polyps. Laryngoscope 117: 2169-2173.
Cavet ME, Volhejn S, Harrington KL & Zhang JZ (2013): Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells. Mol Vis 19: 1515-1525.
Chen Y, Nickola TJ, DiFronzo NL, Colberg-Poley AM & Rose MC (2006): Dexamethasone-mediated repression of MUC5AC gene expression in human lung epithelial cells. Am J Respir Cell Mol Biol 34: 338-347.
Chen Y, Watson AM, Williamson CD et al. (2012): Glucocorticoid receptor and histone deacetylase-2 mediate dexamethasone-induced repression of MUC5AC gene expression. Am J Respir Cell Mol Biol 47: 637-644.
Corfield AP, Carroll D, Myerscough N & Probert CS (2001): Mucins in the gastrointestinal tract in health and disease. Front Biosci 6: D1321-D1357.
Cutolo CA, Barabino S, Bonzano C & Traverso CE (2017): The use of topical corticosteroids for treatment of dry eye syndrome. Ocul Immunol Inflamm. [Epub ahead of print]. 1-10.
Dogru M & Tsubota K (2011): Pharmacotherapy of dry eye. Expert Opin Pharmacother 12: 325-334.
Gipson IK (2001): Mucins of the human endocervix. Front Biosci 6: D1245-D1255.
Gipson IK (2004): Distribution of mucins at the ocular surface. Exp Eye Res 78: 379-388.
Gipson IK (2016): Goblet cells of the conjunctiva: A review of recent findings. Prog Retin Eye Res 54: 49-63.
Gipson IK & Argüeso P (2003): Role of mucins in the function of the corneal and conjunctival epithelia. Int Rev Cytol 231: 1-49.
Gipson IK, Spurr-Michaud S, Argüeso P, Tisdale A, Ng TF & Russo CL (2003): Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. Invest Ophthalmol Vis Sci 44: 2496-2506.
Gipson IK, Spurr-Michaud SJ, Senchyna M, Ritter R 3rd & Schaumberg D (2011): Comparison of mucin levels at the ocular surface of postmenopausal women with and without a history of dry eye. Cornea 30: 1346-1352.
Govindarajan B & Gipson IK (2010): Membrane-tethered mucins have multiple functions on the ocular surface. Exp Eye Res 90: 655-663.
Hos D, Saban DR, Bock F, Regenfuss B, Onderka J, Masli S & Cursiefen C (2011): Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids. Arch Ophthalmol 129: 445-452.
Huynh TP, Barwe SP, Lee SJ et al. (2015): Glucocorticoids suppress renal cell carcinoma progression by enhancing Na,K-ATPase beta-1 subunit expression. PLoS ONE 10: e0122442.
Imai M, Hwang HY, Norris JS & Tomlinson S (2004): The effect of dexamethasone on human mucin 1 expression and antibody-dependent complement sensitivity in a prostate cancer cell line in vitro and in vivo. Immunology 111: 291-297.
Jee D, Park M, Lee HJ, Kim MS & Kim EC (2015): Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome. J Cataract Refract Surg 41: 756-763.
Kadmiel M, Janoshazi A, Xu X & Cidlowski JA (2016): Glucocorticoid action in human corneal epithelial cells establishes roles for corticosteroids in wound healing and barrier function of the eye. Exp Eye Res 152: 10-33.
Lin T & Gong L (2015): Topical fluorometholone treatment for ocular dryness in patients with Sjögren syndrome: a randomized clinical trial in China. Medicine 94: e551.
Machida Y, Shoji J, Harada N & Inada N (2016): Two patients with dry eye disease followed up using an expression assay of ocular surface mucin. Case Rep Ophthalmol 7: 208-215.
Martínez-Antón A, de Bolós C, Alobid I et al. (2008): Corticosteroid therapy increases membrane-tethered while decreases secreted mucin expression in nasal polyps. Allergy 63: 1368-1376.
Milara J, Morell A, Ballester B, Armengot M, Morcillo E & Cortijo J (2017): MUC4 impairs the anti-inflammatory effects of corticosteroids in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 139: 855-862.
Okazaki K, Chiba T & Hajiro K (1998): Downregulation of gastric mucin gene expression and its biosynthesis by dexamethasone in the human. J Clin Gastroenterol 27(Suppl 1): S91-S96.
Pflugfelder SC (2004): Antiinflammatory therapy for dry eye. Am J Ophthalmol 137: 337-342.
Pflugfelder SC, Maskin SL, Anderson B et al. (2004): A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol 138: 444-457.
Pinto-Fraga J, López-Miguel A, González-García MJ et al. (2016): Topical fluorometholone protects the ocular surface of dry eye patients from desiccating stress: a randomized controlled clinical trial. Ophthalmology 123: 141-153.
Ramamoorthy P & Nichols JJ (2008): Mucins in contact lens wear and dry eye conditions. Optom Vis Sci 85: 631-642.
Robertson DM, Li L, Fisher S et al. (2005): Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line. Invest Ophthalmol Vis Sci 46: 470-478.
Rose MC & Voynow JA (2006): Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 86: 245-278.
Stephens DN & McNamara NA (2015): Altered mucin and glycoprotein expression in dry eye disease. Optom Vis Sci 92: 931-938.
Yan H, Wang Y, Shen S, Wu Z & Wan P (2017): Corticosteroids effects on LPS-induced rat inflammatory keratocyte cell model. PLoS ONE 12: e0176639.